It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The relationship between renal impairment and diabetic peripheral neuropathy (DPN) remains inconclusive. We aim to investigate the risk factors for the occurrence of DPN in Taiwanese adults with type 2 diabetes mellitus (T2DM) and focus on renal impairment. A hospital-based study was conducted from 2013 to 2019 and 552 Taiwanese people who had T2DM without DPN at baseline were enrolled. DPN was diagnosed using the Michigan Neuropathy Screening Instrument. Potential risk factors were recorded, including patient’s sociodemographic factors, current medication usage and biochemical markers. As of 2019, 73 developed DPN and 479 had no DPN. The cumulative incidence during the 6-year period was 13.22%. Multivariable logistic regression analysis revealed that lower estimated glomerular filtration rate (eGFR) (odds ratio [OR] 0.98, p = 0.005), advanced age (OR 1.06, p = 0.001), increased body weight (OR 1.04, p = 0.018), duration of DM (OR 1.05, p = 0.036) and male gender (OR 3.69, p = 0.011) were significantly associated with future DPN. In addition, patients with T2DM under the age of 65 with higher serum creatinine concentration (OR 8.91, p = 0.005) and higher baseline HbA1C (OR 1.71, p < 0.001) revealed significantly associated with future DPN. In conclusion, this is the first large scaled hospital-based study with long term follow-up to investigate risk factors for DPN in Taiwanese. Lower eGFR and higher serum creatinine concentration, particularly in people under the age of 65, are predictors of future DPN in Taiwanese people with T2DM. Other predictors included advanced age, increased body weight, duration of DM, male gender for all ages and HbA1c in enrolled patients under the age of 65. Our study not only confirms the association between renal impairment and future DPN but also provides a commonly available assessment to predict the future DPN.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Neurological Institute, Taichung Veterans General Hospital, Taichung City, Taiwan, ROC (GRID:grid.410764.0) (ISNI:0000 0004 0573 0731)
2 Neurological Institute, Taichung Veterans General Hospital, Taichung City, Taiwan, ROC (GRID:grid.410764.0) (ISNI:0000 0004 0573 0731); National Chung Hsing University, Department of Post-Baccalaureate Medicine, College of Medicine, Taichung, Taiwan, ROC (GRID:grid.260542.7) (ISNI:0000 0004 0532 3749)
3 Taichung Veterans General Hospital, Department of Medical Research, Taichung City, Taiwan, ROC (GRID:grid.410764.0) (ISNI:0000 0004 0573 0731)
4 Taichung Veterans General Hospital, Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung City, Taiwan, ROC (GRID:grid.410764.0) (ISNI:0000 0004 0573 0731); Chung Shan Medical University, Department of Medicine, School of Medicine, Taichung City, Taiwan, ROC (GRID:grid.411641.7) (ISNI:0000 0004 0532 2041)